The city of Cincinnati, Ohio, currently has 1 active clinical trials seeking participants for Hepatitis C research studies.
Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy
This is a multicenter, single arm study of Sofosbuvir/Velpatasvir (SOF/VEL) for treatment of chronic hepatitis C infection during pregnancy. Treatment will be initiated during the second or third trimester in approximately 100 pregnant people. Maternal participants will take one SOF/VEL tablet once daily for 12 weeks (84 days) and followed until 12 weeks after treatment completion (postpartum). Infants will be followed from birth until one year of age. The primary objectives are to evaluate the... Read More
Between 18 years and 45 years
Trial Updated:
Locations: The Christ Hospital, Cincinnati, Ohio
Conditions: Hepatitis C, Chronic, Pregnancy; Infection